Takeda Pharmaceutical (TAK) Selling, General & Administrative (2017 - 2026)
Takeda Pharmaceutical (TAK) Selling, General & Administrative (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 317.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -1.80 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 206.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.13 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 439.70 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 449.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.11 Bn | 7.46 Bn | 397.90 Mn | 217.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.80 Bn |
| Mar 31, 2026 | 5.21 Bn |
| Dec 31, 2025 | -1.84 Bn |
| Sep 30, 2025 | -1.72 Bn |
| Jun 30, 2025 | -1.77 Bn |
| Mar 31, 2025 | 5.76 Bn |
| Dec 31, 2024 | -1.78 Bn |
| Sep 30, 2024 | -1.80 Bn |
| Jun 30, 2024 | -1.73 Bn |
| Mar 31, 2024 | 5.76 Bn |
| Dec 31, 2023 | -1.81 Bn |
| Sep 30, 2023 | -1.75 Bn |
| Jun 30, 2023 | -1.81 Bn |
| Mar 31, 2023 | -1.88 Bn |
| Dec 31, 2022 | -1.86 Bn |
| Sep 30, 2022 | -1.80 Bn |
| Jun 30, 2022 | -1.79 Bn |
| Mar 31, 2022 | -1.99 Bn |
| Dec 31, 2021 | -2.03 Bn |
| Sep 30, 2021 | -1.93 Bn |